TrialInternational journal of hematology2018

A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia.

Yuzuru Kanakura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.